Exploring Molecular Switches Application In Modern Therapeutics Download Report
12. Februar 2025 12:03 ET
|
KuicK Research
Delhi, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Molecular switches are integral to cellular function, dictating key processes such as gene expression, signal transduction, and cellular response to stimuli....
Cell Culture Hydrogel Market to Reach $2,136.7 million, Globally, by 2035 at 15% CAGR: Allied Market Research
12. Februar 2025 06:30 ET
|
Allied Market Research INC
Wilmington, Delaware , Feb. 12, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Cell Culture Hydrogel Market By Type of Hydrogel (Natural Hydrogels, Synthetic...
AIM ImmunoTech Releases Virtual Investor “What This Means Segment”
11. Februar 2025 08:45 ET
|
AIM ImmunoTech Inc.
Tom Equels, CEO of AIM ImmunoTech and Professor Casper H.J. van Eijck, MD, PhD, Pancreato-biliary Surgeon at Erasmus MC, discuss the Phase 1b/2 clinical trial involving AIM’s Ampligen® (rintatolimod)...
Survivor Healthcare Joins Together for Supportive Cancer Care
11. Februar 2025 08:08 ET
|
Survivor Healthcare
Survivor Healthcare joins Together for Supportive Cancer Care to expand access to early supportive cancer care through digital health innovation.
Qu Biologics’ Immunomodulator Clears Senescence
10. Februar 2025 08:00 ET
|
Qu Biologics, Inc.
BURNABY, British Columbia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation...
University Cancer & Blood Center’s Dr. Ashley Ray receives oncoplastic breast surgery certification
06. Februar 2025 11:48 ET
|
University, Cancer and Blood Center
University Cancer & Blood Center (UCBC), based in Athens, Georgia, announces that Dr. Ashley Ray now has her certification in oncoplastic breast surgery.
Rakovina Therapeutics Announces Additional Synthesized Compounds in its AI-Driven Cancer Drug Discovery Program
06. Februar 2025 08:30 ET
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing cancer therapies based on DNA-damage response...
CytoMed Therapeutics announces Chairman’s Letter to the Company’s shareholders
06. Februar 2025 07:20 ET
|
CYTOMED THERAPEUTICS LIMITED
SINGAPORE, Feb. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”) today released a letter to shareholders from the Chairman of the Company’s Board...
On-Body Drug Delivery Devices Market Hits US$ 390.7 Million in 2023, Set to Reach US$ 796.1 Million by 2034 with a 6.8% CAGR | TMR Research
05. Februar 2025 10:42 ET
|
Transparency Market Research
Wilmington, Delaware, Transparency Market Research Inc. – , Feb. 05, 2025 (GLOBE NEWSWIRE) -- The global on-body drug delivery devices market is revolutionizing patient care by enabling painless,...
Visadoro Golden Visas (Portugal) Launches Brand New Cancer Research Golden Visa For Visionary Philanthropists
05. Februar 2025 09:10 ET
|
Visadoro Golden Visas
Visadoro Golden Visas (Portugal) just launched a brand new cancer research Golden Visa option for visionary philanthropists.